0001181431-12-011054.txt : 20120223 0001181431-12-011054.hdr.sgml : 20120223 20120223122238 ACCESSION NUMBER: 0001181431-12-011054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120222 FILED AS OF DATE: 20120223 DATE AS OF CHANGE: 20120223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERRARI LOUIS CENTRAL INDEX KEY: 0001513697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12632800 MAIL ADDRESS: STREET 1: 765 WARREN STREET CITY: WARRREN STREET STATE: NJ ZIP: 07090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd335579.xml X0304 4 2012-02-22 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001513697 FERRARI LOUIS SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 EVP, North American Commerical Common Stock, $.01 par value per share 2012-02-22 4 S 0 4100 2.06 D 350503 D These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 21, 2011. /s/ Irina Ishak for Louis Ferrari 2012-02-23